RNU6-752P

Across TCGA pan-cancer cohorts, RNU6-752P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-752P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-752P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-752P expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

KIRC, MESO, and ESCA are the cancer types where RNU6-752P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.454	0.658	.007	72	view →
MESO	OS	Tertile	III,IV	0.098	0.579	.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
BLCA	OS	Tertile	IV	0.153	0.599	.018	27	view →
PAAD	OS	Tertile	All	0.313	0.597	.032	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
LUSC	OS	Tertile	All	0.172	0.660	.005	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SARC	OS	Tertile	All	0.176	0.860	<.001	9	view →
LGG	OS	Tertile	All	1.000	0.430	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-752P–KIRC (DFS)

Open the KIRC breakdown →